Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

Teva Pharmaceutical (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) have launched their biosimilar targeting Johnson & Johnson’s (NYSE ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...

The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...